MAPT and supranuclear palsy, progressive, 1: To get rid of this conundrum, Movement Disorder Society (MDS) criteria (2017) for PSP have introduced the novel diagnostic category “probable 4R-tauopathy” for joint clinical recognition of the patients with PSP and CBD pathology and to facilitate the research on 4R-tau targeted therapeutic strategies (16, 44).